Cargando…
Pompe disease: Shared and unshared features of lysosomal storage disorders
Pompe disease, an inherited deficiency of lysosomal acid α-glucosidase (GAA), is a severe metabolic myopathy with a wide range of clinical manifestations. It is the first recognized lysosomal storage disorder and the first neuromuscular disorder for which a therapy (enzyme replacement) has been appr...
Autores principales: | Lim, Jeong-A, Kakhlon, Or, Li, Lishu, Myerowitz, Rachel, Raben, Nina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620984/ https://www.ncbi.nlm.nih.gov/pubmed/26619007 http://dx.doi.org/10.1080/21675511.2015.1068978 |
Ejemplares similares
-
Impaired autophagy: The collateral damage of lysosomal storage disorders
por: Myerowitz, Rachel, et al.
Publicado: (2020) -
Pompe Disease: New Developments in an Old Lysosomal Storage Disorder
por: Meena, Naresh K., et al.
Publicado: (2020) -
Pompe disease: from pathophysiology to therapy and back again
por: Lim, Jeong-A, et al.
Publicado: (2014) -
Modulation of mTOR signaling as a strategy for the treatment of Pompe disease
por: Lim, Jeong‐A, et al.
Publicado: (2017) -
Crosstalk between 2 organelles: Lysosomal storage of heparan sulfate causes mitochondrial defects and neuronal death in mucopolysaccharidosis III type C
por: Pshezhetsky, Alexey V
Publicado: (2015)